2004　論文・総説（英語） Publications（International）

1	Matsubara K, Kiyomoto H, Moriwaki K, Hara T, Kondo N, Shokoji T, Hitomi H, Aki Y, Aono M, Nishiyama A, Ohmori K and Kohno M. Leptin kinetics during peritoneal dialysis in acutely uremic rats. Nephrology (Carlton). 9: 256-261, 2004.
2	Ichihara A, Hayashi M, Kaneshiro Y, Suzuki F, Nakagawa T, Tada Y, Koura Y, Nishiyama A, Okada H, Uddin MN, Nabi AHMN, Ishida Y, Inagami T and Saruta T. Inhibition of diabetic nephropathy by a decoy peptide corresponding to the “handle” region for non-proteolytic activation of prorenin. J. Clin. Invest. 114: 1128-1135, 2004.
3	Kimura S, Zhang G-X, Nagai Y, Miyata K, Nishiyama A, Shokoji T, Yao L, Fan Y-Y, Rahman M, Fujisawa Y, Miyatake A and Abe Y. Time dependent transition of tempol sensitive reduction of blood pressure in angiotensin II induced hypertension. J. Hypertens. 22: 2161-2168, 2004.
4	Hara T, Takahashi N, Kiyomoto H, Aki Y, Fujioka H, Shokoji T, Matsubara K, Moriwaki K, Kondo N, Kiyomoto K, Hirohata M, Ishizu T, Akiyama K, Nishiyama A, Ohmori K and Kohno M. Reduction of oxidized low-density lipoprotein by the long-term use of vitamin E-coated dialyzers in hemodialysis patients. Dialysis Transplant. 33: 197-202, 2004.
5	Kusudo K, Ishii K, Rahman M, Aki Y, Miyatake A, Kosaka H, Kimura S, Komatsu T, Yokoyama M, Morita K, Abe Y and Nishiyama A. Blood flow-dependent changes in intrarenal nitric oxide levels during anesthesia with halothane or sevoflurane. Eur. J. Pharmacol. 498: 267-273, 2004.
6	Fujisawa Y, Nagai Y, Miyatake A, Takei Y, Miura K, Shokoji T, Nishiyama A, Kimura S and Abe Y. Renal effects of a new member of adrenomedullin family, adrenomedullin 2 in rats. Eur. J. Pharmacol.497: 75-80, 2004.
7	Shokoji T, Fujisawa Y, Kimura S, Rahman M, Kiyomoto H, Kohno M, Abe Y and Nishiyama A. Effects of local administrations of tempol and diethyldithio-carbamic on peripheral nerve activity. Hypertension. 44: 236-243, 2004.
8	Yao L, Kobori H, Rahman M, Seth DM, Shokoji T, Fan Y, Zhang G-X, Kimura S, Abe Y and Nishiyama A. Olmesartan improves endotheline-induced hypertension and oxidative stress in rats. Hypertens. Res. 27: 493-500, 2004.
9	Majid DSA, Nishiyama A, Jackson KE and Castillo A. Inhibition of nitric oxide synthase enhances superoxide activity in canine kidney. Am. J. Physiol. Regul. Intergr. Comp. Physiol. 287: R27-R32, 2004.
10	Nishiyama A, Yao L, Nagai Y, Miyata K, Yoshizumi M, Kagami S, Kondo S, Shokoji T, Kiyomoto H, Kimura S, Kohno M and Abe Y. Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats. Hypertension. 43: 841-848, 2004.
11	Suzaki Y, Yoshizumi M, Kagami S, Nishiyama A, Ozawa Y, Kyaw M, Izawa Y, Kanematsu Y, Tsuchiya K and Tamaki T. BMK1 is activated in glomeruli of diabetic rats and in mesangial cells by high glucose conditions. Kidney Int. 65: 1749-1760, 2004
12	Nishiyama A, Yoshizumi M, Rahman M, Kobori H, Seth DM, Miyatake A, Zhang G-X, Yao L, Hitomi H, Kiyomoto H, Kimura S, Tamaki T, Kohno M and Abe Y. Effects of AT1 receptor blockade on renal injury and mitogen-activated protein activity in Dahl salt-sensitive rats. Kidney Int. 65: 972-981, 2004.
13	Rahman M, Kimura S, Nishiyama A, Hitomi H, Zhang G-X and Abe Y. Angiotensin II stimulates superoxide production via both angiotensin AT1A and AT1B receptors in mouse aorta and heart. Eur. J. Pharmacol. 485: 243-249, 2004.
14	Kobori H and Nishiyama A. Effects of tempol on renal angiotensinogen production in Dahl salt-sensitive rats. Biochem. Biophys. Res. Commun. 315: 746-750, 2004.
15	Nishiyama A, Yoshizumi M, Hitomi H, Kagami S, Kondo S, Miyatake A, Fukunaga M, Tamaki T, Kiyomoto H, Kohno M, Shokoji T, Kimura S and Abe Y. The SOD mimetic tempol ameliorates glomerular injury and reduces MAPK activity in Dahl salt-sensitive rats. J. Am. Soc. Nephrol. 15: 306-315, 2004.
16	Zhang G-X, Kimura S, Nishiyama A, Shokoji T, Rahman M and Abe Y. ROS during the acute phase of angiotensin II hypertension participates in cardiovascular MAPK activation but not vasoconstriction. Hypertension. 43: 117-124, 2004.
17	Nishiyama A, Rahman M and Inscho EW. Role of interstitial ATP and adenosine in the regulation of renal hemodynamics and microvascular function. Hypertens. Res. 27: 791-804, 2004.
18	Navar LG and Nishiyama A. Why are angiotensin concentrations so high in the kidney? Curr. Opin. Nephrol. Hypertens. 13: 107-115, 2004.
19	Ichihara A, Kobori H, Nishiyama A and Navar LG. Renal renin-angiotensin system. In: Kidney and blood pressure regulation. Contrib. Nephrol. 143. Edited by H. Suzuki and T. Saruta. pp. 117-130, 2004. Karger.
20	Kimura S, Zhang GX, Abe Y. Mulfunction of Vascular Control in Lifestyle-Related Disease: Oxidative stress of angiotensin II-induced hypertension: Mitogen-activated protein kinases and blood pressure regulation. Jpn J Pharmacol. (J Pharmacol Sci. に改称)_96: 406-410,2004.
21	M Rahman, A Nishiyama, T Yamamoto, T Shokoji, S Kimura, Y Abe. Tubuloglomerular feedback (TGF) response in Dahl salt-sensitive hypertensive rats. JOURNAL OF PHARMACOLOGICAL SCIENCES 94 265P - 265P 2004.
22	H Kurata, T Fujii, T Katayama, H Tsutsui, M Takaoka, Y Kiso, Y Fujisawa, T Shokoji, A Nishiyama, Y Abe, Y Matsumura. Preventive effect of L-carnosine on ischemic acute renal failure in rats. JOURNAL OF PHARMACOLOGICAL SCIENCES 94 113P - 113P 2004.
23	H Kobori, A Nishiyama. Effects of tempol on renal angiotensinogen production in Dahl salt-sensitive rats. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 315(3) 746 - 750 2004.